http://venturebeat.com/2007/07/26/trans1-aims-to-relieve-lower-back-pain-with-805m-ipo/ News About Tech, Money and Innovation Wed, 25 Nov 2009 02:43:52 +0000 http://wordpress.org/?v=2.8.5 hourly 1 http://venturebeat.com/2007/07/26/trans1-aims-to-relieve-lower-back-pain-with-805m-ipo/comment-page-1/#comment-820853 Leigh Sat, 12 Jul 2008 13:23:37 +0000 http://venturebeat.com/2007/07/26/trans1-aims-to-relieve-lower-back-pain-with-805m-ipo/#comment-820853 Interesting info; and I agree that exercise isn't always the best option. For joint pain, I've found that heating pads and a product called Joint Medic work for me. Interesting info; and I agree that exercise isn’t always the best option. For joint pain, I’ve found that heating pads and a product called Joint Medic work for me.

]]> http://venturebeat.com/2007/07/26/trans1-aims-to-relieve-lower-back-pain-with-805m-ipo/comment-page-1/#comment-803454 Dan (Back Pain Sufferer) Mon, 14 Apr 2008 18:28:45 +0000 http://venturebeat.com/2007/07/26/trans1-aims-to-relieve-lower-back-pain-with-805m-ipo/#comment-803454 Whatever you do, don't exercise! If you exercise in the wrong way you will do more harm than good. I know I did and paid for it :( Whatever you do, don’t exercise! If you exercise in the wrong way you will do more harm than good. I know I did and paid for it

]]> http://venturebeat.com/2007/07/26/trans1-aims-to-relieve-lower-back-pain-with-805m-ipo/comment-page-1/#comment-583060 VentureBeat » Life sciences briefing: Wedneday, Oct. 17, 2007 Wed, 17 Oct 2007 17:46:29 +0000 http://venturebeat.com/2007/07/26/trans1-aims-to-relieve-lower-back-pain-with-805m-ipo/#comment-583060 [...] TranS1 IPO exceeds estimated range, raises $95M for spinal-fusion devices — The Wilmington, N.C., maker of minimally invasive devices for spinal fusion priced its IPO shares at $15 apiece, above its expected range of $12 to $14, raising as much as $95 million on the sale of up to 6.3 million shares. The offering values the company at $281.6 million. Our previous coverage of the firm is here and here. [...] [...] TranS1 IPO exceeds estimated range, raises $95M for spinal-fusion devices — The Wilmington, N.C., maker of minimally invasive devices for spinal fusion priced its IPO shares at $15 apiece, above its expected range of $12 to $14, raising as much as $95 million on the sale of up to 6.3 million shares. The offering values the company at $281.6 million. Our previous coverage of the firm is here and here. [...]

]]> http://venturebeat.com/2007/07/26/trans1-aims-to-relieve-lower-back-pain-with-805m-ipo/comment-page-1/#comment-556180 VentureBeat » Life sciences briefing: Friday, Sept. 28, 2007 Fri, 28 Sep 2007 17:46:26 +0000 http://venturebeat.com/2007/07/26/trans1-aims-to-relieve-lower-back-pain-with-805m-ipo/#comment-556180 [...] yielding a maximum possible take of $88.6 million. See our earlier coverage of TranS1’s IPO here. For more stories on VentureBeat Life Sciences, click here.Tagged co:Durect, co:Imalux, co:Sagent [...] [...] yielding a maximum possible take of $88.6 million. See our earlier coverage of TranS1’s IPO here. For more stories on VentureBeat Life Sciences, click here.Tagged co:Durect, co:Imalux, co:Sagent [...]

]]> http://venturebeat.com/2007/07/26/trans1-aims-to-relieve-lower-back-pain-with-805m-ipo/comment-page-1/#comment-556194 VentureBeat » Life sciences briefing: Friday, Sept. 28, 2007 Fri, 28 Sep 2007 17:46:26 +0000 http://venturebeat.com/2007/07/26/trans1-aims-to-relieve-lower-back-pain-with-805m-ipo/#comment-556194 [...] yielding a maximum possible take of $88.6 million. See our earlier coverage of TranS1’s IPO here. For more stories on VentureBeat Life Sciences, click here.Tagged co:Durect, co:Imalux, co:Sagent [...] [...] yielding a maximum possible take of $88.6 million. See our earlier coverage of TranS1’s IPO here. For more stories on VentureBeat Life Sciences, click here.Tagged co:Durect, co:Imalux, co:Sagent [...]

]]>